Imaging-based Biomarkers as Predictors of Response to Anti-VEGF Therapy in Idiopathic Choroidal Neovascularization

被引:0
|
作者
Agrawal, Surbhi [1 ]
Chawla, Rohan [1 ]
Todi, Vishnu [1 ]
Vohra, Rajpal [1 ]
Azad, Shorya V. [1 ]
机构
[1] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India
关键词
Anti-VEGF; biomarkers; idiopathic choroidal neovascularization; OCT; OCT-A; GROWTH-FACTOR THERAPY; INTRAVITREAL BEVACIZUMAB; PHOTODYNAMIC THERAPY; RANIBIZUMAB; ANGIOGRAPHY; RECURRENCE; TYPE-1;
D O I
10.4103/meajo.meajo_173_21
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: The purpose of this study was to identify biomarkers that predict the response of treatment-naive idiopathic choroidal neovascularization (iCNV) to anti-VEGF treatment.METHODS: Fourteen eyes diagnosed with iCNV underwent a dilated fundus examination, Swept Source Optical Coherence Tomography (SS-OCT) and Optical Coherence Tomography - Angiography (OCT-A), and were given an anti-VEGF injection. The same examinations were repeated at every follow-up visit. Analysis of the pre- and posttreatment images was done to identify possible biomarkers which were evaluated to check association with decreased need for multiple anti-VEGF injections.RESULTS: At presentation, 11 patients showed a compact pattern, while three patients showed an arborizing pattern on OCT angiography (P = 1). On follow-up imaging, seven patients showed a marked response, five patients showed a moderate response, and two patients showed a mild response to anti-VEGF injection. Among the seven patients showing a marked response, only one required a repeat injection (P = 0.03). On analysis of SS-OCT, a novel Retinal Pigment Epithelium (RPE) healing response was observed in posttreatment imaging of six patients (P = 0.59).CONCLUSION: A "marked" response to the first anti-VEGF injection results in a more sustained response and is a positive prognostic factor. RPE healing response is an interesting observation that merits further evaluation. Morphology of neovascular membranes has no effect on long-term need for multiple anti-VEGF injections.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 50 条
  • [21] INTRAVITREAL ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
    Yoon, Jong Uk
    Byun, Yeo Jue
    Koh, Hyoung Jun
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 418 - 424
  • [22] Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy
    Dimopoulos, Spyridon
    Leitritz, Martin Alexander
    Ziemssen, Focke
    Voykov, Bogomil
    Bartz-Schmidt, Karl Ulrich
    Gelisken, Faik
    [J]. CLINICAL OPHTHALMOLOGY, 2015, 9 : 1537 - 1541
  • [23] EVALUATION OF CHOROIDAL NEOVASCULARIZATION BEFORE AND AFTER ANTI-VEGF THERAPY USING OCT ANGIOGRAPHY
    Chanana, B.
    Bharti, S.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : E66 - E66
  • [24] Morphological parameters of myopic choroidal neovascularization as predictive factors of anti-VEGF treatment response
    Castellino, Niccolo
    Parodi, Maurizio Battaglia
    Russo, Andrea
    Toro, Mario Damiano
    Fallico, Matteo
    Bonfiglio, Vincenza
    Maugeri, Agatino Davide
    Avitabile, Teresio
    Longo, Antonio
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [25] Corneal Neovascularization: An Anti-VEGF Therapy Review
    Chang, Jin-Hong
    Garg, Nitin K.
    Lunde, Elisa
    Han, Kyu-Yeon
    Jain, Sandeep
    Azar, Dimitri T.
    [J]. SURVEY OF OPHTHALMOLOGY, 2012, 57 (05) : 415 - 429
  • [26] ANTI-VEGF DRUGS AS THE 2009 FIRST-LINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA
    Cohen, Salomon Y.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1062 - 1066
  • [27] Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization-Associated with Best Vitelliform Macular Dystrophy
    Grigorian, Florin
    Vasconcelos, Huber Martins
    Bailey, Steven T.
    Lujan, Brandon J.
    Campbell, J. Peter
    Lin, Phoebe
    Weleber, Richard G.
    Pennesi, Mark E.
    Yang, Paul
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [28] Clinical impact of COVID-19 on patients with choroidal neovascularization on intravitreal anti-VEGF therapy
    Eleftherios I. Agorogiannis
    Deena Maleedy
    Navid Hakim
    David McDaid
    Laura Silver
    Savita Madhusudhan
    Nicholas A. V. Beare
    [J]. Eye, 2022, 36 : 1113 - 1114
  • [29] A novel inhibitor of soluble epoxide hydrolase synergizes with anti-VEGF therapy in suppressing choroidal neovascularization
    Sulaiman, Rania Sulaiman
    Lee, Bit
    Sun, Wei
    Trinh, Khoa
    Seo, Seung-Yong
    Corson, Timothy William
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [30] Acute Syphilitic Posterior Placoid Chorioretinitis With Subfoveal Choroidal Neovascularization Managed With Anti-VEGF Therapy
    Wai, Karen M.
    Gong, Dan
    Rodriguez, Marianeli
    Cunningham, Emmett T., Jr.
    Vavvas, Demetrios G.
    Eliott, Dean
    [J]. JOURNAL OF VITREORETINAL DISEASES, 2022, 6 (03) : 246 - 250